Cravath Advises Novartis In $470M Genoptix Deal
Pharmaceutical giant Novartis AG said Monday that it would buy laboratory services company Genoptix Inc. for $470 million in cash, expanding its diagnostic services portfolio....To view the full article, register now.
Already a subscriber? Click here to view full article